KRAS and neoplasm: Imbalanced TEADs transcriptional output leads to the signal enhancement of many oncogenes, including KRAS, BRAF, LKB1, NF2, and MYC, and subsequently facilitates tumor progression, metastasis, cancer metabolism, and immunity, and serving as the hallmark of cancer [37].